ZIVO BIOSCIENCE, INC.: 10-Q filed 2015-11-13

Name: ZIVO BIOSCIENCE, INC.: 10-Q filed 2015-11-13
Creator: ZIVO BIOSCIENCE, INC.

What ZIVO BIOSCIENCE, INC. reported in its quarterly report filed 2015-11-13 (fiscal Q3 2015): 24 published measures, 62 facts as tagged in accession 0001078782-15-001815.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-13
Fiscal period: fiscal Q3 2015
Accession: 0001078782-15-001815 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZIVO BIOSCIENCE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	101,796	USD
At 2014-12-31	101,857	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	8,774,636	USD
At 2014-12-31	6,471,025	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-8,672,840	USD
At 2014-12-31	-6,369,168	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	19,914	USD
At 2014-12-31	1,383	USD
At 2014-09-30	101,564	USD
At 2013-12-31	493,104	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,474,599	USD	92
2015-01-01 to 2015-09-30	-4,771,461	USD	273
2014-07-01 to 2014-09-30	-3,340,229	USD	92
2014-01-01 to 2014-09-30	-45,446	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-1,810,360	USD	273
2014-01-01 to 2014-09-30	-2,438,160	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2015-07-01 to 2015-09-30	USD	92
2015-01-01 to 2015-09-30	USD	273
2014-07-01 to 2014-09-30	USD	92
2014-01-01 to 2014-09-30	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,828,891	USD	273
2014-01-01 to 2014-09-30	2,046,620	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-46,696,742	USD
At 2014-12-31	-41,925,281	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	50,000	USD
At 2014-12-31	68,750	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-788,305	USD	92
2015-01-01 to 2015-09-30	-2,392,532	USD	273
2014-07-01 to 2014-09-30	-1,096,442	USD	92
2014-01-01 to 2014-09-30	-2,675,910	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	51,796	USD
At 2014-12-31	33,107	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-187,687	USD	92
2015-01-01 to 2015-09-30	-508,561	USD	273
2014-07-01 to 2014-09-30	-147,977	USD	92
2014-01-01 to 2014-09-30	-383,604	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	8,332,779	USD
At 2014-12-31	6,233,983	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	1,218,689	USD
At 2014-12-31	1,225,589	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	219,938	USD	92
2015-01-01 to 2015-09-30	775,511	USD	273
2014-07-01 to 2014-09-30	508,816	USD	92
2014-01-01 to 2014-09-30	1,305,627	USD	273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	37,892,032	USD
At 2014-12-31	35,427,339	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-09-30	100,000	USD
At 2014-12-31	100,000	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-09-30	-50,000	USD
At 2014-12-31	-31,250	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	1,830,641	USD
At 2014-12-31	1,238,994	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-4,771,461	USD	273
2014-01-01 to 2014-09-30	-45,446	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	225,047	USD	92
2015-01-01 to 2015-09-30	608,893	USD	273
2014-07-01 to 2014-09-30	216,761	USD	92
2014-01-01 to 2014-09-30	726,821	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	0	USD	273
2014-01-01 to 2014-09-30	0	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-6,900	USD	273
2014-01-01 to 2014-09-30	1,701	USD	273

Inspect the source

Entity: ZIVO BIOSCIENCE, INC. / CIK 0001101026
Captured: 2026-09-20T05:23:02.675Z
SEC response SHA-256: a67c6f73387834b08f1985c02ad3ba915b8082582e19652219d78b25a60d946c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001101026.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))